PT Meiji Indonesian Pharmaceutical Industries (Indonesia)

Meiji Indonesian Pharmaceutical Industries is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Dki Jakarta. The company was founded in 1974. Meiji Indonesian Pharmaceutical Industries is a subsidiary of Meiji Seika Pharma Co., Ltd., a prominent Japanese pharmaceutical company. The company was established to cater to the growing demand for pharmaceutical products in Indonesia and the Southeast Asian region. It focuses on the production and distribution of a wide range of pharmaceutical products, including antibiotics, over-the-counter medications, and prescription drugs. The company operates several manufacturing facilities in Indonesia, ensuring high-quality production standards and compliance with international regulations. Meiji Indonesian Pharmaceutical Industries has a strong local presence with multiple branches across major cities in Indonesia, enhancing its distribution network and accessibility to healthcare providers and consumers. Globally, Meiji Seika Pharma Co., Ltd. has a significant presence, with operations in various countries across Asia, Europe, and the Americas. This global footprint allows Meiji Indonesian Pharmaceutical Industries to leverage international expertise and resources to enhance its product offerings and technological capabilities. The company is committed to innovation and research, continuously investing in the development of new pharmaceutical products and therapies. It collaborates with various research institutions and industry partners to advance healthcare solutions and improve patient outcomes. Meiji Indonesian Pharmaceutical Industries is a member of several pharmaceutical and healthcare associations, actively participating in industry initiatives and contributing to the development of the pharmaceutical sector in Indonesia. The company's mission is to provide high-quality, affordable healthcare products to improve the well-being of communities in Indonesia and beyond.